# Study of the Metabolism of Danicopan in Healthy Adults

> **NCT04609696** · PHASE1 · COMPLETED · sponsor: **Alexion Pharmaceuticals, Inc.** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Danicopan: Powder-In-Capsule 1
- **DRUG:** Danicopan: Powder-In-Capsule 2
- **DRUG:** Danicopan: Tablet

## Key facts

- **NCT ID:** NCT04609696
- **Lead sponsor:** Alexion Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-20
- **Primary completion:** 2020-12-07
- **Final completion:** 2020-12-07
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2022-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04609696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04609696, "Study of the Metabolism of Danicopan in Healthy Adults". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04609696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*